The store will not work correctly when cookies are disabled.
4-Amino-N'-(10-oxo-9,10-dihydroanthracene-9-ylidene)butanehydrazide
ID: ALA2283322
PubChem CID: 136264395
Max Phase: Preclinical
Molecular Formula: C18H17N3O2
Molecular Weight: 307.35
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: NCCCC(=O)NN=C1c2ccccc2C(=O)c2ccccc21
Standard InChI: InChI=1S/C18H17N3O2/c19-11-5-10-16(22)20-21-17-12-6-1-3-8-14(12)18(23)15-9-4-2-7-13(15)17/h1-4,6-9H,5,10-11,19H2,(H,20,22)
Standard InChI Key: DRGWMKCELLGMNY-UHFFFAOYSA-N
Molfile:
RDKit 2D
23 25 0 0 0 0 0 0 0 0999 V2000
12.4223 -6.5871 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.7065 -6.1746 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.7065 -5.3496 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.9949 -4.9371 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.1341 -6.1746 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
12.4223 -7.4121 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
11.7065 -7.8246 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
13.1341 -8.6496 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.8499 -9.0621 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.8499 -9.8871 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.1341 -10.2996 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.4223 -9.8871 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.7065 -10.2996 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.9949 -9.8871 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.2790 -10.2996 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.5631 -9.8871 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.5631 -9.0621 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.2790 -8.6496 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.9949 -9.0621 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.7065 -8.6496 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.4223 -9.0621 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.7065 -11.1246 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
10.9949 -4.1121 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
3 4 1 0
6 7 1 0
1 5 2 0
1 6 1 0
8 9 1 0
9 10 2 0
10 11 1 0
11 12 2 0
12 13 1 0
13 14 1 0
14 15 1 0
15 16 2 0
16 17 1 0
17 18 2 0
18 19 1 0
14 19 2 0
19 20 1 0
20 21 1 0
12 21 1 0
8 21 2 0
13 22 2 0
7 20 2 0
4 23 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 307.35 | Molecular Weight (Monoisotopic): 307.1321 | AlogP: 1.84 | #Rotatable Bonds: 4 |
Polar Surface Area: 84.55 | Molecular Species: BASE | HBA: 4 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 11.72 | CX Basic pKa: 9.98 | CX LogP: 1.84 | CX LogD: -0.51 |
Aromatic Rings: 2 | Heavy Atoms: 23 | QED Weighted: 0.72 | Np Likeness Score: -0.52 |
References
1. Bansal SK, Sinha BN, Khosa RL. (2013) -Amino butyric acid analogs as novel potent GABA-AT inhibitors: molecular docking, synthesis, and biological evaluation, 22 (1): [10.1007/s00044-012-0023-0] |